Benefits Collaboration Sample Clauses

Benefits Collaboration. The District will continue a dialogue with the Union in an effort to control costs and optimize the value of the employee benefits programs and to facilitate the approval of meet and confer items related to those programs.
AutoNDA by SimpleDocs
Benefits Collaboration. Except as otherwise specified in the Collective Bargaining Agreement or in this Appendix, the medical, dental, vision, LTD (except for the LTD premium calculation, which will remain the same), life insurance, and flexible spending account benefits and other health and welfare benefits such as, for example, Adoption Assistance, costs, employee contributions and cost-sharing percentage (except as limited below), premiums, deductibles, co-payments, and all other aspects of the health care and welfare plans for West Hershey employees will be the same as those in effect at any given time under the Hershey Company Benefits Program and will be at the same cost and the same options as determined and set by the Company and offered to all Company salaried and hourly U.S. participants in the health care and welfare plans. Notwithstanding this, before implementing any benefit plan changes, the Company will consult with the Union and consider the Union’s suggestions and recommendations regarding such benefit plan changes. The parties agree, effective upon contract ratification, to hold benefit update meetings on an annual basis (no later than August and prior to the roll out of plans to employees and open enrollment for the following year) with the Union’s Business Manager/Business Agent to review active employee health and welfare plan design, current status of such plans, claims data review, costing methodology, and regulatory trends and best practices. The parties may mutually agree at any time to adjust the frequency of these meetings. Prior to receiving confidential information, the Business Manager/Agent must sign a confidentiality agreement in a form acceptable to Hershey. The LTD benefit design presently being offered regarding physical and mental health diagnoses to the Unionized employees shall remain unchanged unless modified and agreed to by the parties. For newly hired employees, effective January 1, 2011, the Union agrees to discontinue the Supplemental Retirement Contribution (SRC) and Retiree Life Insurance Program, as the Company has already done so for all salaried employees. The parties acknowledge that calculating health care premiums is a two-step process done on an annual basis. In step one, the Company determines the cost of the plan by considering a number of factors consistent with generally accepted health care underwriting and actuarial standards, including, but not limited to, claims data, cost trending factors, and health care inflation. In...

Related to Benefits Collaboration

  • Joint Inventions For Subject Inventions conceived or first actually reduced to practice under this Agreement that are joint Subject Inventions made by CONTRACTOR and USER, each Party shall have the option to elect and retain title to its undivided rights in such joint Subject Inventions.

  • School Improvement Plans The School shall develop and implement a School Improvement Plan as required by section 1002.33(9)(n), Florida Statutes and applicable State Board of Education Rules or applicable federal law.

  • Develop programs 1) The Employer will develop and implement health promotion and health education programs, subject to the availability of resources. Each Appointing Authority will develop a health promotion and health education program consistent with the Minnesota Management & Budget policy. Upon request of any exclusive representative in an agency, the Appointing Authority shall jointly meet and confer with the exclusive representative(s) and may include other interested exclusive representatives. Agenda items shall include but are not limited to smoking cessation, weight loss, stress management, health education/self-care, and education on related benefits provided through the health plan administrators serving state employees.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • School Improvement Plan As permitted under IC § 20-10.2-3-1.5, the Charter shall serve as the Charter School's strategic and continuous school improvement and achievement plan (hereafter, the "School Improvement Plan"). To the extent that IC § 20-10.2 applies to the Charter in its function as the School Improvement Plan, the Organizer shall comply with the requirements under IC § 20-10.2.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!